• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.非典型肺炎球菌和口腔链球菌中的氟喹诺酮耐药性:肺炎链球菌氟喹诺酮耐药决定因素水平基因转移的证据
Antimicrob Agents Chemother. 2007 Aug;51(8):2690-700. doi: 10.1128/AAC.00258-07. Epub 2007 Jun 4.
2
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.肺炎链球菌与草绿色链球菌之间氟喹诺酮耐药决定子的体外交换及缓症链球菌中parE-parC区域的基因组组织
J Infect Dis. 1999 Aug;180(2):555-8. doi: 10.1086/314888.
3
Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.具有拓扑异构酶IV重组基因的肺炎链球菌氟喹诺酮耐药菌株的适应性
Antimicrob Agents Chemother. 2008 Mar;52(3):822-30. doi: 10.1128/AAC.00731-07. Epub 2007 Dec 26.
4
Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.通过聚合酶链反应-限制性片段长度多态性和单链构象多态性快速筛选肺炎链球菌中的氟喹诺酮耐药决定因素
J Clin Microbiol. 2006 Mar;44(3):970-5. doi: 10.1128/JCM.44.3.970-975.2006.
5
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.肺炎链球菌临床分离株中导致氟喹诺酮耐药性的突变的遗传分析。
Antimicrob Agents Chemother. 2001 Dec;45(12):3517-23. doi: 10.1128/AAC.45.12.3517-3523.2001.
6
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.新型氟喹诺酮类药物对肺炎链球菌临床分离株的活性,包括那些gyrA、parC和parE基因座发生突变的分离株。
Antimicrob Agents Chemother. 1999 Feb;43(2):329-34. doi: 10.1128/AAC.43.2.329.
7
Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.评估致癌症患者菌血症的草绿色链球菌中氟喹诺酮类耐药的分子基础在种属水平上的变化。
Int J Antimicrob Agents. 2014 Jun;43(6):558-62. doi: 10.1016/j.ijantimicag.2014.01.031. Epub 2014 Mar 27.
8
In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.司帕沙星对肺炎链球菌临床菌株的体外活性,这些菌株在gyrase A和拓扑异构酶IV的喹诺酮耐药决定区(QRDRs)中有特定的氨基酸替代。
J Antimicrob Chemother. 2006 Dec;58(6):1279-82. doi: 10.1093/jac/dkl427. Epub 2006 Oct 20.
9
Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread.肺炎链球菌中拓扑异构酶和回旋酶基因座种内横向DNA转移的分子进化视角,及其对氟喹诺酮耐药性发展和传播的影响
Antimicrob Agents Chemother. 2005 Oct;49(10):4315-26. doi: 10.1128/AAC.49.10.4315-4326.2005.
10
Characterization of recombinant fluoroquinolone-resistant pneumococcus-like isolates.重组氟喹诺酮类耐药肺炎球菌样分离株的特性。
Antimicrob Agents Chemother. 2013 Jan;57(1):254-60. doi: 10.1128/AAC.01357-12. Epub 2012 Oct 31.

引用本文的文献

1
favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones.有利于通过代谢适应而不是耐药来规避氟喹诺酮类药物。
mBio. 2024 Feb 14;15(2):e0282823. doi: 10.1128/mbio.02828-23. Epub 2024 Jan 9.
2
Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome.从一名患有草绿色链球菌休克综合征的中性粒细胞减少患者中分离出的缓症链球菌菌株SVGS_061的全基因组序列
Genome Announc. 2016 Apr 7;4(2):e00259-16. doi: 10.1128/genomeA.00259-16.
3
Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.在体外接触达托霉素后出现的草绿色链球菌中高水平达托霉素耐药性的特征分析。
Antimicrob Agents Chemother. 2015 Apr;59(4):2102-12. doi: 10.1128/AAC.04219-14. Epub 2015 Jan 26.
4
Adaptation of mycoplasmas to antimicrobial agents: Acholeplasma laidlawii extracellular vesicles mediate the export of ciprofloxacin and a mutant gene related to the antibiotic target.支原体对抗菌药物的适应性:莱氏无胆甾原体细胞外囊泡介导环丙沙星及与抗生素靶点相关的突变基因的输出。
ScientificWorldJournal. 2014 Jan 29;2014:150615. doi: 10.1155/2014/150615. eCollection 2014.
5
CovR alleviates transcriptional silencing by a nucleoid-associated histone-like protein in Streptococcus mutans.CovR 缓解了变链球菌核相关组蛋白样蛋白的转录沉默。
J Bacteriol. 2012 Apr;194(8):2050-61. doi: 10.1128/JB.06812-11. Epub 2012 Feb 17.
6
A benchmark of parametric methods for horizontal transfers detection.参数方法在水平转移检测中的基准测试。
PLoS One. 2010 Apr 1;5(4):e9989. doi: 10.1371/journal.pone.0009989.
7
Highly penicillin-resistant multidrug-resistant pneumococcus-like strains colonizing children in Oeiras, Portugal: genomic characteristics and implications for surveillance.高耐青霉素、多重耐药类肺炎球菌样菌株在葡萄牙奥埃拉斯地区儿童中的定植情况:基因组特征及其对监测的影响。
J Clin Microbiol. 2010 Jan;48(1):238-46. doi: 10.1128/JCM.01313-09. Epub 2009 Nov 11.

本文引用的文献

1
Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in Streptococcus pneumoniae, S. mitis and S. oralis.跨越屏障:肺炎链球菌、缓症链球菌和口腔链球菌中一类主要嵌合pbp2x的进化与传播
Int J Med Microbiol. 2007 Nov;297(7-8):503-12. doi: 10.1016/j.ijmm.2007.02.009. Epub 2007 Apr 24.
2
Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.1997年至2005年加拿大肺炎链球菌分离株中氟喹诺酮耐药性增加的分子特征
Antimicrob Agents Chemother. 2007 Jan;51(1):198-207. doi: 10.1128/AAC.00609-06. Epub 2006 Nov 6.
3
Modelling bacterial speciation.模拟细菌物种形成。
Philos Trans R Soc Lond B Biol Sci. 2006 Nov 29;361(1475):2039-44. doi: 10.1098/rstb.2006.1926.
4
Use of the housekeeping genes, gdh (zwf) and gki, in multilocus sequence typing to differentiate Streptococcus pneumoniae from Streptococcus mitis and Streptococcus oralis.利用管家基因gdh(zwf)和gki进行多位点序列分型,以区分肺炎链球菌与缓症链球菌和口腔链球菌。
Diagn Microbiol Infect Dis. 2006 Nov;56(3):321-4. doi: 10.1016/j.diagmicrobio.2006.04.013. Epub 2006 Jun 12.
5
Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.通过聚合酶链反应-限制性片段长度多态性和单链构象多态性快速筛选肺炎链球菌中的氟喹诺酮耐药决定因素
J Clin Microbiol. 2006 Mar;44(3):970-5. doi: 10.1128/JCM.44.3.970-975.2006.
6
Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread.肺炎链球菌中拓扑异构酶和回旋酶基因座种内横向DNA转移的分子进化视角,及其对氟喹诺酮耐药性发展和传播的影响
Antimicrob Agents Chemother. 2005 Oct;49(10):4315-26. doi: 10.1128/AAC.49.10.4315-4326.2005.
7
Using multilocus sequence data to define the pneumococcus.利用多位点序列数据定义肺炎链球菌。
J Bacteriol. 2005 Sep;187(17):6223-30. doi: 10.1128/JB.187.17.6223-6230.2005.
8
Phenotypic and genotypic discrepancy of Streptococcus pneumoniae strains isolated from Asian countries.从亚洲国家分离出的肺炎链球菌菌株的表型和基因型差异。
FEMS Immunol Med Microbiol. 2005 Jul 1;45(1):63-70. doi: 10.1016/j.femsim.2005.01.012. Epub 2005 Feb 19.
9
Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.在美国侵袭性肺炎链球菌分离株中,II型拓扑异构酶基因的种间重组并非氟喹诺酮耐药性的主要原因。
Antimicrob Agents Chemother. 2005 Feb;49(2):779-80. doi: 10.1128/AAC.49.2.779-780.2005.
10
The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.具有喹诺酮耐药性突变的肺炎链球菌的分子流行病学
Clin Infect Dis. 2005 Jan 15;40(2):225-35. doi: 10.1086/426817. Epub 2004 Dec 21.

非典型肺炎球菌和口腔链球菌中的氟喹诺酮耐药性:肺炎链球菌氟喹诺酮耐药决定因素水平基因转移的证据

Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.

作者信息

Ip Margaret, Chau Shirley S L, Chi Fang, Tang Julian, Chan Paul K

机构信息

Department of Microbiology, Chinese University of Hong Kong, The Prince of Wales Hospital, Hong Kong.

出版信息

Antimicrob Agents Chemother. 2007 Aug;51(8):2690-700. doi: 10.1128/AAC.00258-07. Epub 2007 Jun 4.

DOI:10.1128/AAC.00258-07
PMID:17548487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1932522/
Abstract

Atypical strains, presumed to be pneumococcus, with ciprofloxacin MICs of > or =4.0 microg/ml and unique sequence variations within the quinolone resistance-determining regions (QRDRs) of the gyrase and topoisomerase genes in comparison with the Streptococcus pneumoniae R6 strain, were examined. These strains were reidentified using phenotypic methods, including detection of optochin susceptibility, bile solubility, and agglutination by serotype-specific antisera, and genotypic methods, including detection of pneumolysin and autolysin genes by PCR, 16S rRNA sequencing, and multilocus sequence typing (MLST). The analysis based on concatenated sequences of the six MLST loci distinguished the "atypical" strains from pneumococci, and these strains clustered closely with S. mitis. However, all these strains and five of nine strains from the viridans streptococcal group possessed one to three gyrA, gyrB, parC, and parE genes whose QRDR sequences clustered with those of S. pneumoniae, providing evidence of horizontal transfer of the QRDRs of the gyrase and topoisomerase genes from pneumococci into viridans streptococci. These genes also conferred fluoroquinolone resistance to viridans streptococci. In addition, the fluoroquinolone resistance determinants of 32 well-characterized Streptococcus mitis and Streptococcus oralis strains from bacteremic patients were also compared. These strains have unique amino acid substitutions in GyrA and ParC that were distinguishable from those in fluoroquinolone-resistant pneumococci and the "atypical" isolates. Both recombinational events and de novo mutations play an important role in the development of fluoroquinolone resistance.

摘要

对非典型菌株进行了检测,这些菌株被推测为肺炎球菌,其环丙沙星的最低抑菌浓度(MIC)≥4.0μg/ml,与肺炎链球菌R6菌株相比,其gyrase和topoisomerase基因的喹诺酮耐药决定区(QRDRs)内存在独特的序列变异。使用表型方法对这些菌株进行了重新鉴定,包括检测对奥普托欣的敏感性、胆汁溶解性以及通过血清型特异性抗血清进行凝集试验,还使用了基因型方法,包括通过PCR检测肺炎溶血素和自溶素基因、16S rRNA测序以及多位点序列分型(MLST)。基于六个MLST位点串联序列的分析将“非典型”菌株与肺炎球菌区分开来,这些菌株与缓症链球菌紧密聚类。然而,所有这些菌株以及来自草绿色链球菌群的九株菌株中的五株,都拥有一至三个gyrA、gyrB、parC和parE基因,其QRDR序列与肺炎链球菌的序列聚类,这为gyrase和topoisomerase基因的QRDRs从肺炎球菌水平转移到草绿色链球菌提供了证据。这些基因也赋予了草绿色链球菌对氟喹诺酮的耐药性。此外,还比较了32株来自菌血症患者的特征明确的缓症链球菌和口腔链球菌菌株的氟喹诺酮耐药决定因素。这些菌株在GyrA和ParC中具有独特的氨基酸取代,与耐氟喹诺酮肺炎球菌和“非典型”分离株中的不同。重组事件和从头突变在氟喹诺酮耐药性发展中都起着重要作用。